178 related articles for article (PubMed ID: 21640497)
21. Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research.
Yao M; Nguyen T; Buatti JM; Dornfeld KJ; Tan H; Wacha J; Bayouth JE; Clamon GH; Funk GF; Smith RB; Chang K; Hoffman HT
Am J Clin Oncol; 2006 Dec; 29(6):606-12. PubMed ID: 17148999
[TBL] [Abstract][Full Text] [Related]
22. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma.
Raktoe SA; Dehnad H; Raaijmakers CP; Braunius W; Terhaard CH
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):136-41. PubMed ID: 22541959
[TBL] [Abstract][Full Text] [Related]
23. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
[TBL] [Abstract][Full Text] [Related]
24. Cervical nodal level V can safely be omitted in the treatment of locally advanced oropharyngeal squamous cell carcinoma with definitive IMRT.
Gutiontov S; Leeman J; Lok B; Romesser P; Riaz N; Tsai CJ; Lee N; McBride S
Oral Oncol; 2016 Jul; 58():27-31. PubMed ID: 27311399
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma.
Clavel S; Nguyen DH; Fortin B; Després P; Khaouam N; Donath D; Soulières D; Guertin L; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):582-9. PubMed ID: 21277695
[TBL] [Abstract][Full Text] [Related]
26. Concurrent chemoradiotherapy with helical tomotherapy for oropharyngeal cancer: a preliminary result.
Shueng PW; Wu LJ; Chen SY; Hsiao CH; Tien HJ; Cheng PW; Kuo YS; Chen YJ; Chen CA; Hsieh PY; Hsieh CH
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):715-21. PubMed ID: 19879069
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma: impact of extracapsular nodal spread on distant metastases.
Kuhnt T; Klockenbrink U; Knipping S; Lautermann J; Kriese K; Wienke A; Hildebrandt G; Hauptmann S
Strahlenther Onkol; 2011 May; 187(5):292-9. PubMed ID: 21533760
[TBL] [Abstract][Full Text] [Related]
28. Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma.
Lee NCJ; Kelly JR; Park HS; An Y; Judson BL; Burtness BA; Husain ZA
Oral Oncol; 2018 Oct; 85():35-39. PubMed ID: 30220317
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.
Mendenhall WM; Amdur RJ; Morris CG; Kirwan JM; Li JG
Laryngoscope; 2010 Nov; 120(11):2218-22. PubMed ID: 20938964
[TBL] [Abstract][Full Text] [Related]
30. Definitive intensity-modulated radiotherapy concurrent with systemic therapy for oropharyngeal squamous cell carcinoma: Outcomes from an integrated regional Australian cancer centre.
Masoud Rahbari R; Winkley L; Hill J; Tahir AR; McKay M; Last A; Shakespeare TP; Dwyer P
J Med Imaging Radiat Oncol; 2016 Jun; 60(3):414-9. PubMed ID: 26786975
[TBL] [Abstract][Full Text] [Related]
31. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma.
Gunn GB; Blanchard P; Garden AS; Zhu XR; Fuller CD; Mohamed AS; Morrison WH; Phan J; Beadle BM; Skinner HD; Sturgis EM; Kies MS; Hutcheson KA; Rosenthal DI; Mohan R; Gillin MT; Frank SJ
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):360-367. PubMed ID: 27084653
[TBL] [Abstract][Full Text] [Related]
32. Treatment outcomes of locally advanced oropharyngeal cancer: a comparison between combined modality radio-chemotherapy and two variants of single modality altered fractionation radiotherapy.
Kader HA; Mydin AR; Wilson M; Alexander C; Shahi J; Pathak I; Wu JS; Truong PT
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1030-6. PubMed ID: 20675071
[TBL] [Abstract][Full Text] [Related]
33. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).
Eisbruch A; Harris J; Garden AS; Chao CK; Straube W; Harari PM; Sanguineti G; Jones CU; Bosch WR; Ang KK
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1333-8. PubMed ID: 19540060
[TBL] [Abstract][Full Text] [Related]
34. Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement.
Hodges JC; Das P; Eng C; Reish AG; Beddar AS; Delclos ME; Krishnan S; Crane CH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):791-4. PubMed ID: 19231109
[TBL] [Abstract][Full Text] [Related]
35. Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer.
Lee H; Ahn YC; Oh D; Nam H; Kim YI; Park SY
Head Neck; 2014 Apr; 36(4):499-504. PubMed ID: 23780633
[TBL] [Abstract][Full Text] [Related]
36. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
Dirix P; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
[TBL] [Abstract][Full Text] [Related]
37. Outcomes utilizing intensity-modulated radiotherapy in oropharyngeal cancers: Tonsils versus base of tongue.
Kanakamedala MR; Giri SPG; Hamilton RD; Bhanat E; Vijayakumar S
Head Neck; 2018 May; 40(5):1034-1039. PubMed ID: 29385294
[TBL] [Abstract][Full Text] [Related]
38. Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance.
Mohindra P; Urban E; Pagan JD; Geye HM; Patel VB; Bayliss RA; Bender ET; Harari PM
Head Neck; 2016 Apr; 38(4):499-505. PubMed ID: 25445257
[TBL] [Abstract][Full Text] [Related]
39. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
[TBL] [Abstract][Full Text] [Related]
40. Reducing radiotherapy target volume expansion for patients with HPV-associated oropharyngeal cancer.
Burr AR; Harari PM; Ko HC; Bruce JY; Kimple RJ; Witek ME
Oral Oncol; 2019 May; 92():52-56. PubMed ID: 31010623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
